1832 Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.43M Buy
+26,034
New +$1.43M ﹤0.01% 526
2024
Q4
Sell
-1,164,391
Closed -$81.8M 654
2024
Q3
$81.8M Buy
1,164,391
+1,141,200
+4,921% +$80.2M 0.06% 155
2024
Q2
$1.91M Buy
23,191
+3,470
+18% +$286K ﹤0.01% 496
2024
Q1
$1.72M Sell
19,721
-717,500
-97% -$62.7M ﹤0.01% 522
2023
Q4
$71.1M Buy
737,221
+263,781
+56% +$25.4M 0.1% 149
2023
Q3
$41.9M Buy
473,440
+92,719
+24% +$8.2M 0.06% 185
2023
Q2
$33M Buy
380,721
+229,415
+152% +$19.9M 0.04% 215
2023
Q1
$14.7M Sell
151,306
-974,500
-87% -$94.8M 0.02% 296
2022
Q4
$117M Sell
1,125,806
-276,246
-20% -$28.6M 0.19% 95
2022
Q3
$119M Buy
1,402,052
+200,170
+17% +$17M 0.22% 91
2022
Q2
$99.6M Buy
1,201,882
+701,500
+140% +$58.1M 0.17% 110
2022
Q1
$38.1M Buy
500,382
+110,490
+28% +$8.41M 0.05% 235
2021
Q4
$34.7M Buy
389,892
+60,842
+18% +$5.42M 0.06% 202
2021
Q3
$25.4M Buy
329,050
+217,413
+195% +$16.8M 0.05% 239
2021
Q2
$9.17M Hold
111,637
0.02% 319
2021
Q1
$8.28M Buy
+111,637
New +$8.28M 0.02% 309
2020
Q3
Sell
-979,300
Closed -$119M 685
2020
Q2
$119M Buy
979,300
+940,078
+2,397% +$114M 0.36% 79
2020
Q1
$3.22M Buy
+39,222
New +$3.22M 0.01% 341
2015
Q4
Sell
-9,900
Closed -$1.05M 660
2015
Q3
$1.05M Sell
9,900
-1,600
-14% -$169K ﹤0.01% 390
2015
Q2
$1.57M Sell
11,500
-2,000
-15% -$273K 0.01% 426
2015
Q1
$1.69M Buy
13,500
+1,100
+9% +$137K 0.01% 384
2014
Q4
$1.12M Sell
12,400
-7,100
-36% -$641K ﹤0.01% 433
2014
Q3
$1.41M Buy
19,500
+100
+0.5% +$7.22K ﹤0.01% 426
2014
Q2
$1.21M Hold
19,400
﹤0.01% 445
2014
Q1
$1.29M Sell
19,400
-2,100
-10% -$139K ﹤0.01% 442
2013
Q4
$1.51M Buy
21,500
+6,300
+41% +$443K 0.01% 385
2013
Q3
$1.1M Buy
+15,200
New +$1.1M ﹤0.01% 336